Saving Money With Cheap Prescription Drugs
Friday, March 12th, 2010Generic drugs are drugs that are manufactured and sold as a cheaper version of the brand named product. Whilst $4 generic drugs have not patented their active ingredient, their unique formulation may be patented.
America’s FDA (Food and Drug Administration) governs medications such as these and consider generic drugs as identical to brand name on a legal basis. The same laws apply to cheap generic drugs as their brand named formula in terms of dose, strength, safety and administration. Generics have to be within an acceptable bioequivalent range and must contain the same active ingredients.
Once the patent of the original developer expires, generic medications become available. When this happens, competition in the market lends itself to lower costs for both the generics and the brand name products.
Whilst patents are valid for 20 years on drugs in the USA, it is only really active for about a decade as developers have to apply for a patent before they begin with clinical trials.
Health insurance companies and the consumer save a lot of money with generic drugs. When drugs are no longer patent protected, pharmacological companies have lower costs in developing the generic drug that enables them to uphold profitability and therefore the savings are passed on to the patient. Even developing countries are able to afford generic drugs easily.
India is the world leader in generic drug manufacturing and generic drugs are distributed from there to many developing countries. Generics are created by applying reverse engineering to brand named formulations to create bioequivalent generics thereof. Generics don’t need to undergo clinical trials proving safety and effectiveness, which also saves time and money.
Generic drug companies leverage off the marketing efforts of the brand name drug, which after a number of years on the market has become well-known to healthcare professionals. These same professional can now easily switch over their patients from the branded product to the generic medication.
During the patent protection period, the brand name company monopolizes the market and therefore they can price the product in order to maximize profitability. Usually, during this time the drug is highly over-priced. This gives them the funds to research and develop new drugs. Most generic medication manufacturers cannot afford this.
Legally, generic drugs can be produced in the instances where either the brand name’s patent has expired, when the generic manufacturer can certify that the brand name’s patents are invalid, for drugs that have never held patents, or where the country does not enforce drug patents. Certain patents may only apply in certain countries.
On expiration of a patent, the monopoly is also removed. Patents are not normally renewable. Should the branded drug’s formulation change significantly in a new improved formulation, a new patent will have to be applied for. Clinical trials will also have to be done again. Generic versions can continue to be sold despite the changes to the original drug, unless regulators remove it off the market.
The cheap generic drugs are welcomed by health care professionals and their patients. The import of generic medication to developing countries means better health care for all.